The impact of (poly)phenol-rich foods and extracts on flow-mediated dilation (FMD): a narrative review

Brian Óg Murphy1, Holly R Neill1, Niamh Magee1

  • 1Nutrition Innovation Centre for Food and Health (NICHE), School of Biomedical Sciences, Ulster University, Coleraine, UK. c.gill@ulster.ac.uk.

Food & Function
|October 27, 2025
PubMed

Insights

Polyphenol-rich foods like berries, cocoa, and tea significantly improve endothelial function, measured by flow-mediated dilation (FMD). A food-first approach shows promise for cardiovascular health, but food matrix effects require further study.

Area of Science:

  • Nutritional Science
  • Cardiovascular Health
  • Biochemistry

Background:

  • Cardiovascular disease (CVD) is a leading global health concern, with endothelial dysfunction as a critical precursor.
  • Flow-mediated dilation (FMD) is the gold standard for assessing endothelial function.
  • Dietary (poly)phenols are known to positively influence endothelial function.

Purpose of the Study:

  • To evaluate the efficacy of various (poly)phenol-rich foods and extracts on endothelial function (FMD).
  • To assess the feasibility of a food-first approach for improving vascular health.
  • To review the impact of different food matrices and intake patterns on (poly)phenol bioavailability and efficacy.

Main Methods:

  • Systematic literature search of human clinical trials in PubMed and Web of Science.
  • Analysis of studies measuring flow-mediated dilation (FMD) response to (poly)phenol intake.
  • Narrative review synthesizing evidence on specific food groups and their impact on endothelial function.

Main Results:

  • Berries, cocoa, and tea show robust evidence for consistently improving FMD, with chronic intake sustaining benefits.
  • Grape-derived (poly)phenols exhibit variable effects, requiring more detailed compositional data for substantiation.
  • Citrus and coffee (poly)phenols show variable FMD responses, with mechanistic support for vascular health benefits from citrus.
  • The food matrix (e.g., milk, sugar) can attenuate FMD responses, while fortification may maintain bioactivity.

Conclusions:

  • A food-first approach incorporating (poly)phenol-rich foods like berries, cocoa, and tea can improve endothelial function and cardiovascular health.
  • Understanding food matrix effects and optimizing intake through strategies like fortification are crucial for maximizing benefits.
  • Further research is needed to refine dietary guidelines, establish intake thresholds, and explore dose-response relationships for long-term cardiovascular protection.

Related Concept Videos

Bioavailability: Overview01:13

Bioavailability: Overview

Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Factors Influencing Drug Absorption: Drug Dissolution01:27

Factors Influencing Drug Absorption: Drug Dissolution

The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Modified-Release Drug Delivery Systems: Bioavailability01:30

Modified-Release Drug Delivery Systems: Bioavailability

Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...